Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Change in Inventory (2016 - 2025)

Arcadia Biosciences (RKDA) has disclosed Change in Inventory for 12 consecutive years, with -$33000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Inventory rose 81.67% year-over-year to -$33000.0, compared with a TTM value of $622000.0 through Sep 2025, up 51.34%, and an annual FY2024 reading of -$550000.0, down 122.74% over the prior year.
  • Change in Inventory was -$33000.0 for Q3 2025 at Arcadia Biosciences, down from $204000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $2.0 million in Q3 2021 and bottomed at -$669000.0 in Q1 2022.
  • Average Change in Inventory over 5 years is $194000.0, with a median of -$33000.0 recorded in 2025.
  • The sharpest move saw Change in Inventory surged 2293.62% in 2023, then tumbled 918.92% in 2024.
  • Year by year, Change in Inventory stood at -$268000.0 in 2021, then skyrocketed by 82.46% to -$47000.0 in 2022, then soared by 2293.62% to $1.0 million in 2023, then tumbled by 93.21% to $70000.0 in 2024, then crashed by 147.14% to -$33000.0 in 2025.
  • Business Quant data shows Change in Inventory for RKDA at -$33000.0 in Q3 2025, $204000.0 in Q2 2025, and $381000.0 in Q1 2025.